Potential Indications served by AMBS Assets |
Parkinson's Disease (PD) |
Amyotrophic Lateral Sclerosis (ALS) - Lou Gehrig's Disease |
Ischemic Heart Disease |
Alzheimer's Disease (AD) |
Huntington's Disease |
Traumatic Brain Injury/ Chronic Traumatic Encephalopathy (TBI/CTE) |
ischaemic stroke |
Bipolar Disorder Acute Lung Injury (ALI) Post-ischemic neurological recovery non-alcoholic steatohepatitis (NASH) |
maintaining circadian plasticity of neurons |
Umbilical Cord Mesenchymal Stem Cells for treating Spinal Cord Injury |
Charcot-Marie-Tooth disease (CMT) |
cancer immunotherapy |
Retinitis Pigmentosa (RP); and, |
other Inherited Retinal Disorders |
Multiple Sclerosis Experimental autoimmune encephalomyelitis |
Control of Energy Homeostasis |
Liver Damage |
Aging |
Heart Attack |
Bacterial Myocarditis |
Age-related macular degeneration |
MANF in Acetaminophen (APAP)-induced liver injury (AILI) |
Glaucoma |
Post-Operative Delirium via Inhibiting Inflammation and Microglia Activation |
Sporadic Retinal Disorders |
Other degenerative disorders and retinal injury |
Wolfram's Syndrome |
Diabetes Type-1 |
Diabetes Type-2 |
type 2 diabetes mellitus |
Osteoarthritis, |
Parabiosis |
alcoholic pancreatitis |
Septic Renal Injury |
Diagnosis of Parkinson's Disease |
Assays for diagnosis and therapeutics |
47 Protein Biomarkers for Neurodegenerative Diseases |
Assays for Amyotrophic Lateral Sclerosis (ALS) and ALS-like disorders |
Diagnosis of Alzheimer's Disease |
Alzheimer's Disease (AD) |
TBI/CTE |
Parkinson's Disease Levodopa Induced Dyskinesia (PD-LID) |
Attention Deficit Hyperactivity Disorder (ADHD) |
Lipidomics Assay |
Exosomes Assay |
Four additional Assays |
Congenital Hairy Nevus |
Type 3 and 4 intractable severe burns |
MSPrecise Diagnostic for Multiple Sclerosis (MS) |
Neurosarcoid Diagnostic Assay |
Neuromeylitis optica Diagnostic Assay |
Para neoplastic Disease Diagnostic Assay |
Amyotrophic Lateral Sclerosis (ALS) Diognostic Assay |